Sage Therapeutics
SAGE
#7028
Rank
โ‚น49.44 B
Marketcap
โ‚น787.58
Share price
0.00%
Change (1 day)
16.09%
Change (1 year)

Earnings for Sage Therapeutics (SAGE)

Earnings in 2025 (TTM): -โ‚น25.64 Billion

According to Sage Therapeutics 's latest financial reports the company's current earnings are โ‚น70.41 Million. In 2024 the company made an earning of -โ‚น36.36 Billion, an increase over its 2023 earnings that were of -โ‚น49.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sage Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น25.64 Billion-29.49%
2024 -โ‚น36.36 Billion-26.01%
2023 -โ‚น49.14 Billion1.63%
2022 -โ‚น48.35 Billion16.36%
2021 -โ‚น41.55 Billion-175.55%
2020 โ‚น54.99 B-189.1%
2019 -โ‚น61.73 Billion82.43%
2018 -โ‚น33.84 Billion38.04%
2017 -โ‚น24.51 Billion69.9%
2016 -โ‚น14.43 Billion68.25%
2015 -โ‚น8.58 Billion179.48%
2014 -โ‚น3.07 Billion84.98%
2013 -โ‚น1.66 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-โ‚น4.31 Billion-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
โ‚น3.23 B-111.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
โ‚น46.50 B-270.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-โ‚น5.27 Billion-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA